(Q46937067)

26 December 2017

title

Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis (English)

1 reference

26 December 2017

1 reference

9

Gordon Mills

1 reference

26 December 2017

author name string

Mandi Murph

1

1 reference

26 December 2017

Tamotsu Tanaka

2

1 reference

26 December 2017

Jihai Pang

3

1 reference

26 December 2017

Edward Felix

4

1 reference

26 December 2017

Shuying Liu

5

1 reference

26 December 2017

Rosanne Trost

6

1 reference

26 December 2017

Andrew K Godwin

7

1 reference

26 December 2017

Robert Newman

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

26 December 2017

published in

Methods in Enzymology

1 reference

26 December 2017

volume

433

1 reference

26 December 2017

page(s)

1-25

1 reference

26 December 2017

Lanthanide complexes as fluorescent indicators for neutral sugars and cancer biomarkers.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Plasma lysophosphatidic acid concentration and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Sphingosine kinase 1 is up-regulated in colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Expression, regulation and function of autotaxin in thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Sphingosine-1-phosphate: an enigmatic signalling lipid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Identification of a lysophosphatidylserine receptor on mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Lysophosphatidic acid production and action: validated targets in cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Lysophospholipids activate ovarian and breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

Autotaxin expression in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933001-2

7 January 2021

10.1016/S0076-6879(07)33001-2

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017